Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Muecksch

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Nature Communications|January 18, 2023
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escapeLeander Witte, Viren A Baharani, Fabian Schmidt, et al.
The Journal of Experimental Medicine|August 14, 2024
Transcription of HIV-1 at sites of intact latent provirus integrationAna Rafaela Teixeira, Cintia Bittar, Gabriela S Silva Santos, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Transcription of HIV-1 at sites of intact latent provirus integrationAna Rafaela Teixeira, Cintia Bittar, Gabriela S Silva Santos, et al.
The New England Journal of Medicine|April 21, 2021
Vaccine Breakthrough Infections with SARS-CoV-2 VariantsEzgi Hacisuleyman, Caryn Hale, Yuhki Saito, et al.
The Lancet. Microbe|May 31, 2022
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysisFrauke Muecksch, Helen Wise, Kate Templeton, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunityFrauke Muecksch, Helen Wise, Kate Templeton, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection <i>in vivo</i>Alexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Cell Reports|September 17, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 PatientsLarry L Luchsinger, Brett Ransegnola, Daniel Jin, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Nature Communications|January 18, 2023
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escapeLeander Witte, Viren A Baharani, Fabian Schmidt, et al.
The Journal of Experimental Medicine|August 14, 2024
Transcription of HIV-1 at sites of intact latent provirus integrationAna Rafaela Teixeira, Cintia Bittar, Gabriela S Silva Santos, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Transcription of HIV-1 at sites of intact latent provirus integrationAna Rafaela Teixeira, Cintia Bittar, Gabriela S Silva Santos, et al.
The New England Journal of Medicine|April 21, 2021
Vaccine Breakthrough Infections with SARS-CoV-2 VariantsEzgi Hacisuleyman, Caryn Hale, Yuhki Saito, et al.
The Lancet. Microbe|May 31, 2022
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysisFrauke Muecksch, Helen Wise, Kate Templeton, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunityFrauke Muecksch, Helen Wise, Kate Templeton, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection <i>in vivo</i>Alexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Cell Reports|September 17, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 PatientsLarry L Luchsinger, Brett Ransegnola, Daniel Jin, et al.
Pageof 7